DexCom Inc (NASDAQ:DXCM) over-valued by 10%
| Website | http://www.dexcom.com |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $32,134,406,144 |
| Beta | 0.751241 |
| Average Volume | $800,200 |
| Last Dividend | 0% |
| Price on Feb 14, 2022 | $454.73 |
| Autochartist™ Valuation | $408.31 |
| Conclusion |
10% over-valued |
| Download Report |
